AVMA-animal care

合集下载

多种配方-法国维克

多种配方-法国维克
派愈妥的活性成分为过氧化苯甲酰,专用于 改善犬的深层脓皮症及由于蠕形螨和脂溢性 皮炎造成的皮肤疾病。
维克 爱 体 洁
治疗浅表脓皮症和真菌感染引起的皮肤病
爱体洁是一款温和抗过敏杀菌香波。爱体洁 应用球丽技术和甲壳素两款突破性技术帮助 护理皮肤。
适应症
治疗及控制细菌和脂溢性皮炎。可单独或与其他药物联合使用。 去除皮肤多余脏污和控制细菌过度繁殖,及由细菌和蠕形螨引 起的皮肤病。
维克 爱乐美
有效缓解并改善瘙痒、红斑等皮肤问题
爱乐美内含有必需脂肪酸,同时具有舒缓, 免疫调节,抗菌剂的作用;是一款专用于 犬猫过敏性皮肤的泡沫型微乳液。
适应症
有效缓解并改善因异位性皮炎或其他过敏性皮肤病所引起的皮肤 问题,如瘙痒、红斑和微生物过度生长等,同时帮助重建犬猫敏 感皮肤的天然防御屏障。 爱乐美中的创新成分帮助: - 控制皮肤免疫和炎症反应 - 加强皮肤结构完整性和维持表皮屏障功能 (必需脂肪酸) - 重建皮肤生态环境微生物平衡 (匹罗克酮乙醇胺)
洗澡期间
使用温水浸湿毛发,请勿直接用水 冲洗爱宠头部。
25℃
在爱宠颈部和背部使用香波按摩, 帮助香波渗透到被毛内部。如有必 要,可适量加水。
温水充分冲洗。
5-15 Min
重复之前的过程,使香波停留在 宠物的被毛上5-10分钟再冲洗。
充分冲洗直至水干净为止。
洗澡后
避免冷风,引起感冒。 用毛巾擦干,或使用吹风机吹干。 最后,为长毛犬梳理毛发。
使用方法
将爱皮舒用于温水湿润过的犬猫被毛上。将产品均衡涂均匀。 轻轻按摩后冲洗。每周使用1-2次。请根据兽医师的建议使用。
储存
避免长时间存放于超过摄氏30度以上的环境中
注意事项
仅外用,避免与眼睛接触,避免皮肤过敏症状的发生。

动物保健十大品牌简介

动物保健十大品牌简介

动物保健十大品牌简介汇报人:2023-12-19•普莱柯生物•绿康生化•瑞普生物目录•回盛生物•中牧股份•生物股份•永顺生物•华农生物目录•银禧科技•海利生物01普莱柯生物成立于1994年,是中国农业科学院洛阳惠中兽药有限公司与洛阳惠中兽药有限公司合资成立的洛阳惠中兽药有限公司成立时间1.2亿人民币注册资本洛阳惠中兽药有限公司总部地点兽用生物制品、兽用药物制剂、饲料添加剂、混合型饲料添加剂的研发、生产与销售经营范围公司简介疫苗产品药物产品检测试剂技术服务产品与服务01020304猪用疫苗、禽用疫苗、牛羊用疫苗等抗寄生虫药、抗菌药、抗感染药等猪瘟抗原检测试剂盒、猪繁殖与呼吸综合征检测试剂盒等提供疫病诊断、技术咨询等服务国家高新技术企业国家级企业技术中心国家技术创新示范企业中国兽药制剂生产企业50强等荣誉荣誉与成就0103020405中国动物保健行业百强企业02绿康生化绿康生化股份有限公司成立于2003年,是一家专注于兽药研发、生产和销售的企业。

成立时间总部地点经营范围总部位于福建省厦门市,拥有现代化的生产基地和研发中心。

涵盖兽药原料药、制剂、生物制品以及饲料添加剂等多个领域。

030201公司简介绿康生化主要生产兽药原料药,包括抗生素、抗寄生虫药、解热镇痛药等。

兽药原料药绿康生化拥有多种制剂产品,如注射剂、片剂、散剂等,满足不同养殖需求。

制剂产品绿康生化还研发和生产了一系列生物制品,如疫苗、诊断试剂等。

生物制品绿康生化提供多种饲料添加剂,如维生素、矿物质、氨基酸等,提高动物生长性能。

饲料添加剂产品与服务荣誉与成就国家级高新技术企业绿康生化被认定为国家级高新技术企业,拥有多项发明专利和实用新型专利。

行业地位绿康生化在兽药行业中具有较高的知名度和影响力,产品畅销国内外市场。

社会责任绿康生化积极履行社会责任,关注环保和公益事业,致力于推动行业可持续发展。

03瑞普生物成立于1997年,是中国最大的动物保健公司之一。

美国兽医协会(AVMA) 推荐的动物安乐死方法

美国兽医协会(AVMA) 推荐的动物安乐死方法

附录A
AVMA推荐的安乐死方法
(规范性附录)
附表A.美国兽医协会(AVMA)推荐的动物安乐死方法
首选方法有条件情况下的可选方法(需要辅助方法)
啮齿类动物(静脉或腹腔)注射巴比妥类药物或
其复方组合、分离剂(例如氯胺酮)
的复方组合吸入麻醉药、CO
2
、CO、亚硝酸、乙醇、颈椎脱臼、断颈、集中微波照射法
兔静脉注射巴比妥类药物吸入过量麻醉药、CO
2
、颈椎脱臼、头部击碎
犬静脉注射巴比妥类药物、过量麻醉药巴比妥类药物(其他途径)、吸入过量麻醉药、
CO、CO
2、
枪击法
猫静脉注射巴比妥类药物、过量麻醉药巴比妥类药物(其他途径)、吸入过量麻醉药、
CO、CO
2、
枪击法
非人灵长类动物(静脉或腹腔)注射巴比妥类药物、
过量麻醉药
吸入麻醉药、CO、CO
2
猪(静脉或腹腔)注射巴比妥类药物CO
2、N
2
、Ar、CO、枪击法、电击、非头部击碎、
钝力外伤
牛静脉注射巴比妥类药物枪击法、头部击碎马静脉注射巴比妥类药物头部击碎、枪击法
两栖动物(静脉或腹腔)注射巴比妥类药物、
分离剂和麻醉药、表面麻醉用三卡因
甲磺酸酯或苯佐卡因盐酸盐吸入麻醉药、CO
2
、头部击碎、头部钝力外伤、快速冷冻
爬行动物(静脉或腹腔)注射巴比妥类药物、
分离剂和麻醉药吸入麻醉药、CO
2
、头部击碎器、头部钝力外伤、<4g动物快速冷冻
家禽(静脉或腹腔)注射巴比妥类药物、
过量麻醉药CO
2
、N
2
、Ar、CO、颈椎脱臼、断颈、钝力外伤、电击、头部击碎器
4。

6N137SD,6N137SD,6N137SD,HCPL2631SD,HCPL2631SD,HCPL2631SD,6N137,6N137S, 规格书,Datasheet 资料

6N137SD,6N137SD,6N137SD,HCPL2631SD,HCPL2631SD,HCPL2631SD,6N137,6N137S, 规格书,Datasheet 资料

8 1
8 1
8 1
Truth Table (Positive Logic)
Input
Enable
H
H
L
H
H
L
L
L
H
NC
L
NC
Output L H H H L H
©2005 Fairchild Semiconductor Corporation 6N137, HCPL2601, HCPL2611, HCPL2630, HCPL2631 Rev. 1.0.8
Dual Channel
VE = 0.5V
IEL
Low Level Enable Current VCC = 5.5V, VE = 0.5V
IEH
High Level Enable Current VCC = 5.5V, VE = 2.0V
VEH High Level Enable Voltage VCC = 5.5V, IF = 10mA
V EL
Low Level Enable Voltage VCC = 5.5V, IF = 10mA(3)
Min.
5.0
2.0
Typ.* Max. Unit
1.8
V
1.4 1.75
V
60
pF
-1.4Βιβλιοθήκη mV/°C710
mA
10
15
9
13
mA
14
21
-0.8 -1.6 mA
-0.6 -1.6 mA
V
0.8
Symbol
IFL IFH VCC VEL VEH TA N
Parameter Input Current, Low Level Input Current, High Level Supply Voltage, Output Enable Voltage, Low Level Enable Voltage, High Level Low Level Supply Current Fan Out (TTL load)

简历动物医学专业 自我评价

简历动物医学专业 自我评价

简历动物医学专业自我评价英文回答:As a highly skilled and experienced animal healthcare professional with a deep understanding of animal anatomy, physiology, and pathology, I am confident in my ability to excel in a challenging and rewarding role in the animal medical field. Throughout my academic and professional journey, I have consistently demonstrated a passion for animal welfare and a commitment to providing exceptional care to all creatures.My educational background in animal medicine has equipped me with a solid foundation in veterinary science.I possess a comprehensive understanding of animal anatomy, physiology, and pathology, as well as proficiency in diagnostic techniques and treatment protocols. Additionally, I have gained valuable hands-on experience through internships and clinical rotations at renowned veterinary hospitals, where I assisted in a wide range of surgical andmedical procedures.Beyond my technical expertise, I am also highly proficient in communication and interpersonal skills. I am able to build rapport with clients and effectively convey medical information and treatment options, ensuring that they are well-informed and involved in the decision-making process. My ability to work effectively as part of a team and collaborate with other healthcare professionals is also a key strength.Furthermore, I am an active member of several professional organizations, including the American Veterinary Medical Association (AVMA) and the American Association of Veterinary Clinicians (AAVC). This involvement has allowed me to stay abreast of the latest advancements in animal medicine and connect with other professionals in the field.I am eager to contribute my knowledge, skills, and compassion to an organization that is dedicated to providing exceptional animal care. I am confident that mypassion for animal welfare and my commitment to excellence will make me a valuable asset to your team.中文回答:作为一名拥有丰富经验的高技能动物保健专业人士,我对动物的解剖学、生理学和病理学有着深刻的理解,我对自己在动物医疗领域具有挑战性和有价值的角色中取得成功的能力充满信心。

美国兽医协会(AVMA)简介

美国兽医协会(AVMA)简介

美国兽医协会(AVMA)简介李靖;汪明【期刊名称】《中国兽医杂志》【年(卷),期】2017(053)012【总页数】2页(P116-117)【作者】李靖;汪明【作者单位】中国农业大学动物医学院,北京海淀100193;中国农业大学动物医学院,北京海淀100193【正文语种】中文1 AVMA简介美国兽医协会(American Veterinary Medical Association,简称AVMA)是一个非盈利组织,旨在为兽医会员和兽医行业发声。

AVMA现在拥有超过89 000名会员,来自兽医行业的不同领域,例如私人动物诊所,大型动物医院,政府,畜牧业,学术界,以及军队有关机构。

AVMA总部位于美国伊利诺伊州的绍姆堡市,靠近芝加哥市。

另外,AVMA也有一个下属部门常驻美国的首都华盛顿,其功能主要是和政府沟通,推动和影响政府有关兽医方面的立法。

AVMA同时也是一个私营组织,必须遵守联邦以及所在州的法律法规。

根据美国联邦法对于非盈利组织的有关规定,AVMA的运营可以免税。

AVMA是成立于1863年。

目前有约600名志愿人员和约150名职工在为AVMA 服务,其中约四分之一为兽医。

在美国,75%的兽医为AVMA的会员。

AVMA致力于成为兽医界的领导者,保护、促进和推动兽医行业的融合和进步并促使其满足社会需要。

AVMA的协会使命是通过为会员宣传发声而领导兽医行业,促进兽医科技和兽医从业的进步并改善动物和人类的健康。

2 会员制度AVMA的会员资格要求申请人满足AVMA的章程规定并支持协会的发展目标。

除了AVMA的章程之外,会员还需遵守兽医从业道德标准原则以及其他相关的协会政策、规定和管理条款。

具有选举权的会员为具备特定权利的个体兽医,这些权利包括选举该兽医所在选区的主管、具备担任管理委员会成员或众议院成员资格等。

附属会员(Affiliate members)为在兽医领域担任教职或者参与兽医科研的非兽医。

所有的会员都必须每年交纳年费(目前为330美元),并可以免费订阅AVMA所办的两本杂志之一,即美国兽医协会杂志(JAVMA)或美国兽医科研杂志(AJVR)。

AAALAC 认证

AAALAC 认证

AAALAC 认证私营组织AAALAC(Association for Assessment and Accreditation of Laboratory Animal Care International)是一个权威的评估和认证动物饲养和使用标准的国际机构,它要求在生物科学、医药领域人道、科学地对待动物。

为了保证动物实验的质量,美国食品药品监督管理局和欧共体强力推荐在AAALAC 认证的实验室开展动物实验。

世界500强医药巨头联合申明,它们医药产品的动物实验都将在AAALAC认证单位完成。

目前,全球已有700多家制药和生物技术公司、大学、医院和其他机构获得了AAALAC的国际认证。

认证后出售的非人灵长类动物,每只在3500-4500美元。

中国有几家企业正在申请AAALAC认证,这是中国非人灵长类动物贸易新的效益增长点。

申请机构按照AAALAC“认证规则”,确定具有申请资格后,进行认证申请的程序如下:1.提交申请资料,交纳认证费。

申请书包括三部分:第一部分是申请机构的简介;第二部分与《实验动物饲养管理和使用手册》(以下简称《手册》)的章节几乎对应,申请机构逐项回答问题;第三部分是附录图表资料。

申请书提交给认证委员会办公室后,会收到AAALAC的回函。

在交纳认证费用后,认证办公室会通知认证的时间和认证专家组等有关事宜。

2.现场评审。

AAALAC选派的评审专家组不少于2人,评审前可进行交流。

现场评审通常需要2天以上,一般以会议形式开始:申请机构负责人介绍机构情况,专家介绍AAALAC情况及评审安排。

专家审阅有关文件资料记录和实地考察动物设施和仪器设备,检查过程中申请机构应有熟悉情况的负责人员陪同,及时回答专家的提问。

全部检查结束后专家组讨论,提出意见,并向认证委员会提交正式的评审报告;此期间申请机构还可以提交一些补充或改正的报告资料,以完善评审报告。

3.认证的确定与类别。

AAALAC认证委员会一般在每年的1月、5月和9月分别召开认证委员会,讨论此前的各个现场评审专家组报告,评价该机构符合《手册》的情况以及存在问题的严重程度,委员会成员投票决定某项认证的类别。

AAMI标准

AAMI标准

Association for the Advancement of Medical Instrumentation协会中文名称:AAMI;美国医疗器械促进协会1 AAMI 7198-1998 (R 2004) CARDIOVASCULAR IMPLANTS - TUBUAL VASCULAR PROSTHESES-FDA RECOGNIZED2 AAMI 10993-1-2003 Biological evaluation of medical devices - Part 1: Evaluation and testing-FDA RECOGNIZED3 AAMI 10993-2-2006 Biological evaluation of medical devices - Part 2: Animal welfare requirements4 AAMI 10993-3-2003 Biological Evaluation of Medical Devices, Part 3: Tests for Genotoxicity, Carcinogenicity and Reproductive Toxicity5 AAMI 10993-4-2002 Biological evaluation of medical devices - Part 4: Selection of tests for interaction with blood-Incorporates Amendment 1: 20066 AAMI 10993-5-1999 BIOLOGICAL EVALUATION OF MEDICAL DEVICES, PART 5: TEST FOR IN VITRO CYTOTOXICITY-FDA RECOGNIZED7 AAMI 10993-6-1995 (R 2001) BIOLOGICAL EVALUATION OF MEDICAL DEVICES, PART 6: TESTS FOR LOCAL EFFECTS AFTER IMPLANTATION-FDA RECOGNIZED8 AAMI 10993-7-1995 (R 2001) Biological Evaluation of Medical Devices, Part 7: Ethylene Oxide Sterilization Residuals-Only FDA RECOGNIZED if used in conjunction to AAMI TIR19: 1988; Replaces AAMI ST29: 1988 and AAMI ST30: 1989 [Use: AAMI TIR19 AMD 1]9 AAMI 10993-9-1999 (R 2005) Biological evaluation of medical devices - Part 9: for identification and quantification of potential degradation products10 AAMI 10993-11-2006 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity11 AAMI 10993-12-2002 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials-FDA RECOGNIZED12 AAMI 10993-13-1999 (R 2004) Biological evaluation of medical devices, Part 13: Identification and quantification of degradation products from polymeric devices.13 AAMI 10993-14-2001 (R 2006) BIOLOGICAL EVALUATION OF MEDICAL DEVICES, PART 14: IDENTIFICATION AND QUANTIFICATION OF DEGRADATION PRODUCT FROM CERAMICS14 AAMI 10993-15-2000 (R 2006) Biological evaluation of medical devices?Part 15: Identification and quantification of degradation products from metals and alloys15 AAMI 10993-16-1997 (R 2003) BIOLOGICAL EVALUATION OF MEDICAL DEVICES - PART 16: TOXICOKINETIC STUDY DESIGN FOR DEGRADATION PRODUCTS AND LEACHABLES FROM MEDICAL DEVICES16 AAMI 10993-17-2002 BIOLOGICAL EVALUATION OF MEDICAL DEVICES, PART17: ESTABLISHMENT OF ALLOWABLE LIMITS FOR LEACHABLE SUBSTANCES17 AAMI 11135 ERTA-2005 Medical devices ?Validation and routine control of ethylene oxide sterilization-Erratum issued: 20 January 1995 (print copy only) and Erratum issued: 6 April 2005 (PDF copy only)18 AAMI 11135-1994 Medical devices - Validation and routine control of ethylene oxide sterilization-FDA RECGOGNIZED; esignations: AAMI OPEO, AAMI ST27, and AAMI TIR1 [Refer to: AAMI TIR14, AAMI TIR15, AAMI TIR16, AAMI TIR20, AAMI TIR28]19 AAMI 11137-1-2006 Sterilization of health care products - Radiation - Part 1: Requirements for the development, validation and routine control of a sterilization process for medical devices-Also replaces AAMI ST31, AAMI ST32, AAMI TIR520 AAMI 11137-3-2006 Sterilization of health care products - Radiation - Part 3: Guidance on dosimetric aspects-Also replaces AAMI ST31, AAMI ST32, AAMI TIR521 AAMI 11138-1-2006 Sterilization of health care products - Biological indicators - Part 1: General requirements [Refer to: AAMI 18472] 22 AAMI 11138-2-2006 Sterilization of health care products - Biological indicators - Part 2: Biological indicators for ethylene oxide sterilization processes [Refer to: AAMI 18472]23 AAMI 11138-3-2006 Sterilization of health care products - Biological indicators - Part 3: Biological indicators for moist heat sterilization processes [Refer to: AAMI 18472]24 AAMI 11138-4-2006 Sterilization of health care products - Biological indicators - Part 4: Biological indicators for dry heat sterilization processes [Refer to: AAMI 18472]25 AAMI 11138-5-2006 Sterilization of health care products - Biological indicators - Part 5: Biological indicators for low-temperature steam and aldehyde sterilization processes [Refer to: AAMI 18472]26 AAMI 11607-2-2006 Packaging for terminally sterilized medical devices - Part 2: Validation requirements for ing, sealing and assembly processes27 AAMI 11737-2-1998 Sterilization of Medical Devices - Microbiological Methods - Part 2: Tests of Sterility Per ed in the Validation of a Sterilization Process-FDA RECOGNIZED28 AAMI 13485-2003 Medical devices - Quality management systems - Requirements for regulatory purposes29 AAMI 14155-1-2003 Clinical investigation of medical devices for human subjects - Part 1: General requirements30 AAMI 14155-2-2003 Clinical investigation of medical devices for human subjects?Part 2: Clinical investigation plans31 AAMI 14160-1998 Sterilization of Single-Use Medical Devices Incorporating Materials of Animal Origin - Validation and Routine Control of Sterilization by Liquid Chemical Sterilants-FDA RECOGNIZED32 AAMI 14161-2000 Sterilization of health care products?Biological indicators?Guidance for the selection, use, and interpretation of results-FDA RECOGNIZED33 AAMI 14937-2000 Sterilization of health care products?General requirements for characterization of a sterilizing agent and the development, validation, and routine control of a sterilization process for medical devices-FDA RECOGNIZED34 AAMI 15223-2000 Medical Devices - Symbols to be used with medical device labels, labeling and in ation to be supplied.-FDA RECOGNIZED; Includes Amendment 1: 11/5/2001 and Amendment 2: 4/23/200435 AAMI 15225-2000 (R 2006) NOMENCLATURE - SPECIFICATION FOA A NOMENCLATURE SYSTEM FOR MEDICAL DEVICES FOR THE PURPOSE OF REGULATORY DATA EXCHANGE-Includes Amendment 1: 200436 AAMI 15674-2001 Cardiovascular implants and artificial organs —Hard shell cardiotomy/venous reservoir systems (with/without filter) and soft venous reservoir bags37 AAMI 15675-2001 Cardiovascular implants and artificial organs?Cardiopulmonary bypass systems?Arterial blood line filters38 AAMI 15882-2003 Sterilization of health care products - Chemical indicators - Guidance for selection, use, and interpretation of results-FDA RECOGNIZED39 AAMI 17665-1-2006 Sterilization of health care products - Moist heat - Part 1 Requirements for the development, validation and routine control of a sterilization process for medical devices- er Designation: AAMI ST2540 AAMI 25539-1 AMD 1-2005 Cardiovascular implants - Endovascular devices - Part 1: Endovascular prostheses, Amendment 1: Test methods 41 AAMI 25539-1-2003 Cardiovascular implants?Endovascular devices?Part 1: Endovascular prostheses42 AAMI 60601-2-21-2000 Medical electrical equipment, Part 2: Particular requirements for the safety of infant radiant warmers-FDA RECOGNIZED; er Designation: AAMI II52; Incorporates Amendment 1: 2000 43 AAMI 62304-2006 Medical device software - Software life cycle processes [Refer to: AAMI TIR32]44 AAMI BE78-2002 BIOLOGICAL EVALUATION OF MEDICAL DEVICES, PART 10: TEST FOR IRRITATION AND DELAYED TYPE HYPERSENSITIVITY-In place of AAMI 10993-10; FDA RECOGNIZED45 AAMI BE83-2006 Biological evaluation of medical devices - Part 18: Chemical characterization of materials46 AAMI BF7-1989 (R 2002) Blood Transfusion Micro-Filters-FDA RECOGNIZED47 AAMI BF64-2002 LEUKOCYTE REDUCTION FILTERS48 AAMI 7199-1996 (R 2002) Cardiovascular implants and artificial organs - Blood-ga* **changers (oxygenators)49 AAMI BP22-1994 (R 2006) Blood Pressure Transducers-FDA RECOGNIZED; Incorporates Errata: 08/05/200450 AAMI 5840-2005 Cardiovascular implants - Cardiac valve prostheses-FDA RECOGNIZED51 AAMI DF80-2003 Medical electrical equipment, Part 2: Particular requirements for the safety of cardiac defibrillators [including automated external defibrillators]-Also repalces AAMI TIR252 AAMI EC11-1991 (R 2001) Diagnostic electrocardiographicdevices-FDA RECOGNIZED53 AAMI EC12-2000 (R 2005) Disposable ECG Electrodes-FDA RECOGNIZED54 AAMI EC13 ERTA-2002 Cardiac Monitors, Heart Rate Meters and Alarms55 AAMI EC13-2002 Cardiac Monitors, Heart Rate Meters and Alarms56 AAMI EC38-1998 Ambulatory Electrocardiographs-FDA RECOGNIZED57 AAMI EC53 ERTA-2001 ECG cables and leadwires-Includes Erratum issued: 31 May 199858 AAMI EC53-1995 (R 2001) ECG cables and leadwires59 AAMI EC57-1998 (R 2003) Testing and reporting per ance results of cardiac rhythm and ST segment measurement algorithms-Includes Errata: 4/14/2004; Revision of ECAR: 1987; FDA-Recognized60 AAMI EC71-2001 Standard Communications Protocol - Computer Assisted Electrocardiography-Proposed equivalency to IEC60601-2-53/Ed.1: Harmonized61 AAMI EQ56-1999 (R 2004) Recommended practices for a medical equipment management program62 AAMI ES60601-1-2005 Medical electrical equipment, Part 1: General requirements for basic safety and essential per ance63 AAMI HE48-1993 Human Factors Engineering Guidelines and Preferred Practices for the Design of Medical Devices64 AAMI HE74-2001 Human Factors Design Process for MedicalDevices-FDA RECOGNIZED65 AAMI HFMD-1996 An Introduction to Human Factors in Medical Devices66 AAMI ID26 ERTA-2006 Medical electrical equipment, Part 2: Particular requirements for the safety of infusion pumps and controllers 67 AAMI ID54-1996 (R 2005) Enteral Feeding Set Adapters and Connectors-FDA RECOGNIZED68 AAMI NS4-1986 (R 2002) Transcutaneous Electrical Nerve Stimulators69 AAMI NS14-1995 (R 2002) Implantable spinal cord stimulators70 AAMI NS15-1995 (R 2002) Implantable peripheral nerve stimulators71 AAMI NS28-1988 (R 2006) Intracranial Pressure Monitoring Devices-FDA RECOGNIZED; Incorporates Errata: 06/200172 AAMI PAC49-1993 (R 2000) Pacemaker Emergency Intervention System73 AAMI PB70-2003 LIQUID BARRIER PER ANCE AND CLASSIFICATION OF PROTECTIVE APPAREL AND DRAPES INTENDED FOR USE IN HEALTH CAREFACILITIES-FDA RECOGNIZED74 AAMI PC69-2000 ACTIVE IMPLANTABLE MEDICAL DEVICES ELECTROMAGNETIC COMPATIBILITY EMC TEST PROTOCOLS FOR IMPLANTABLE CARDIAC PACEMAKERS AND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS75 AAMI RD5-2003 Hemodialysis Systems76 AAMI RD16 AMD 1-2002 (R 2005) Hemodialyzers-FDA RECOGNIZED77 AAMI RD16-1996 (R 2005) Hemodialyzers [Refer to: IEC 60601-2-16]78 AAMI RD17-1994 (R 2005) Hemodialyzer Blood Tubing-Includes Amendment 1: 200279 AAMI RD47-2002 Reuse of Hemodialyzers-Incorporates Amendment 1: 7/2003 and Errata: 07/200380 AAMI RD52-2004 Dialysate for hemodialysis81 AAMI RD62-2006 WATER TREATMENT EQUIPMENT FOR HEMODIALYSIS APPLICATIONS82 AAMI SP10-2006 Manual, electronic, or automated sphygmomanometers-FDA REGOGNIZED; Incorporates Amendment 1: 2003; Amendment 2: 200683 AAMI ST8-2001 Hospital Steam Sterilizers-FDA RECOGNIZED84 AAMI ST24-1999 (R 2005) Automatic, General-Purpose Ethylene Oxide Sterilizers and Ethylene Oxide Sterilant Sources Intended for Use in Health Care Facilities-FDA RECONIZED85 AAMI ST40-2004 Table-top dry heat (heated air) sterilization and sterility assurance in health care facilities-FDA RECOGNIZED86 AAMI ST41-1999 (R 2005) Ethylene Oxide Sterilization in Health Care Facilities: Safety and Effectiveness-FDA RECOGNIZED87 AAMI ST50-2004 Dry Heat (Heated Air) Sterilizers-FDA RECOGNIZED88 AAMI ST55-2003 Table-Top Steam Sterilizers-FDA RECOGNIZED89 AAMI ST63-2002 Sterilization of health care products—Requirements for the development, validation, and routine control of an industrial sterilization process for medical devices—Dry heat-FDA RECOGNIZED90 AAMI ST65-2000 PROCESSING OF REUSABLE SURGICAL TEXTILES FOR USE IN HEALTH CARE FACILITIES91 AAMI ST66-1999 STERILIZATION OF HEALTHCARE PRODUCTS - CHEMICAL INDICATORS - PART 2 : CLASS 2 INDICATORS FOR AIR REMOVAL TEST SHEETS AND PACKS-FDA RECOGNIZED [Refer to: AAMI 18472]92 AAMI ST67-2003 Sterilization of health care products—Requirements for products labeled “STERILE?FDA RECOGNIZED93 AAMI ST77-2006 Containment devices for reusable medical device sterilization94 AAMI ST81-2004 Sterilization of medical devices - In ation to be provided by the manufacturer for the processing of resterilizable medical devices-FDA RECOGNIZED95 AAMI TIR4-1989 Apnea Monitoring by Means of Thoracic ImpedancePneumography96 AAMI TIR11-2005 Selection and use of protective apparel and surgical drapes in health care facilities97 AAMI TIR12-2004 Designing, Testing and Labeling Reusable Medical Devices for Reprocessing in Health Care Facilities: A Guide for Device Manufacturers-2nd Edition98 AAMI TIR13-1997 Principles of Industrial Moist HeatSterilization-(Updated material from ANSI/AAMI ST25:1987 )99 AAMI TIR14-1997 Contract Sterilization for EthyleneOxide-Updated material from AAMI ST27; Cited by FDA as "relevant guidance" for ANSI/AAMI/ISO 11135: 1994; Includes Amendment 1: 2004 [Refer to: AAMI 11135 ERTA]100 AAMI TIR15-1997 Ethylene Oxide Sterilization Equipment, Process Considerations and Pertinent Calculations-Updated material from AAMI ST27; Cited by FDA as "relevant guidance" for ANSI/AAMI/ISO 11135: 1994 [Refer to: AAMI 11135 ERTA]101 AAMI TIR16-2000 PROCESS DEVELOPMENT AND PER ANCE QUALIFICATION FOR ETHYLENE OXIDE STERILIZATION - MICROBIOLOGICAL ASPECTS-Updated material from AAMI ST27; Cited by FDA as "relevant guidance" forANSI/AAMI/ISO 11135: 1994 [Refer to: AAMI 11135 ERTA]102 AAMI TIR17-1997 Radiation Sterilization MaterialQualification-Cited by FDA as "relevant guidance" for ANSI/AAMI/ISO 11137: 1994; Replaces AAMI ST32 [Refer to: AAMI 11137]103 AAMI TIR18-1997 Guidance on Electromagnetic Compatibility of Medical Devices for Clinical/Biomedical Engineers - Part 1: Radiated Radio-Frequency Electromagnetic Energy [Replaced by: IEC 61326-2-6] 104 AAMI TIR19 AMD 1-1999 Guidance for ANSI/AAMI/ISO 10993-7:1995, Biological evaluation of medical deices—Part 7: Ethylene oxide sterilization residuals Amendment105 AAMI TIR19-1998 Guidance for ANSI/AAMI/ISO 10993-7:1995, Biological Evaluation of Medical Devices - Part 7: Ethylene Oxide Sterilization Residuals-Replaces AAMI ST29 and AAMI ST30; Cited as relevant guidance to FDA-recognized standard ANSI/AAMI/ISO 10993-7 [Refer to: AAMI 10993-7]106 AAMI TIR20-2001 PARAMETRIC RELEASE FOR ETHYLENE OXIDE STERILIZATION-Cited by FDA as "relevant guidance" for ANSI/AAMI/ISO 11135: 1994 [Refer to: AAMI 11135 ERTA]107 AAMI TIR21-1998 Systems Used to Forecast Remaining Pacemaker Battery Service Life108 AAMI TIR22-1998 Guidance for ANSI/AAMI/ISO 11607, Packaging for Terminally Sterilized Medical Devices-AMD 1: 2001109 AAMI TIR23-1999 Signal Averaging110 AAMI TIR24-1999 Acquisition and use of physiologic wave databases for testing of medical devices111 AAMI TIR26-2000 Ventricular assist and heart replacement systems 112 AAMI TIR28-2001 PRODUCT ADOPTION AND PROCESS EQUIVALENCY FOR ETHYLENE OXIDE STERILIZATION [Refer to: ISO 11135, AAMI 11135 ERTA] 113 AAMI TIR29-2002 GUIDE FOR PROCESS CONTROL IN RADIATION STERILIZATION-Cited by FDA as "relevant guidance" for ANSI/AAMI/ISO 11137: 1994 [Refer to: AAMI 11137]114 AAMI TIR30-2003 A Compendium of processes, materials, test methods, and acceptance criteria for cleaning reusable medical devices 115 AAMI TIR31-2003 PROCESS CHALLENGE DEVICES/TEST PACKS FOR USE IN HEALTH CARD FACILITIES116 AAMI TIR32-2004 Medical device software risk management [Refer to: AAMI 14971, AAMI 62304]117 AAMI TIR35-2006 Sterilization of health care products - Radiation sterilization - Alternative sampling plans for verification dose experiments and sterilization dose audits- er designation: AAMI ST31, AAMI ST32, and AAMI TIR5118 AAMI TIR10993-19-2006 Biological evaluation of medical devices - Part 19: Physico-chemical, morphological and topographical characterization of materials119 AAMI TIR10993-20-2006 Biological evaluation of medical devices - Part 20: Principles and methods for immunotoxicology testing of medical devices120 AAMI TIR11139-2006 Sterilization of health careproducts ?Vocabulary121 AAMI TIR14969-2004 Medical devices—Quality management systems?Guidance on the application of ISO 13485:2003122 AAMI TIR15844-1998 Sterlization of Health Care Products - Radiation Sterlization - Selection of a Sterilization Dose for a Single Production Batch-Edition 1123 AAMI TIR16142-2005 Guidance on the selection of standards in support of recognized essential principles of safety and per ance of medical devices-2006 printing124 AAMI TIR19218-2006 Medical devices - Coding structure for adverse event type and cause125 AAMI TIR60878-2003 Graphical symbols for electrical equipment in medical practice126 AAMI TIR62296-2003 Considerations of unaddressed safety aspects in the Second Edition of IEC 60601-1 and proposals for new requirements [Refer to: IEC 60601-1]127 AAMI TIR62348-2006 Mapping between the clauses of the third edition of IEC 60601-1 and the 1988 edition as amended。

美国临床兽医博士(DVM)与执业兽医和官方兽医的关系

美国临床兽医博士(DVM)与执业兽医和官方兽医的关系

2018年第35卷第 4 期美国临床兽医博士(DVM)与执业兽医和官方兽医的关系王媛媛,郝峰强,李卫华(中国动物卫生与流行病学中心,山东青岛 266032)摘 要:临床兽医博士(DVM)是美国特有的一种学位,主要侧重于临床技能操作和应用,对于促进美国执业兽医制度建设和兽医职业化发展发挥了重要作用。

本文介绍了DVM学位获得过程,分析了DVM与执业兽医、官方兽医的关系。

在美国,取得DVM学位仅是具备了参加北美兽医资格考试(NA VLE)和州执照考试的一种资格,并不能直接开展兽医执业工作。

由兽医官、消费安全检验员、屠宰场食品检验员、州兽医、认证兽医等组成的美国官方兽医队伍中,既有取得DVM学位的,也有符合条件未取得DVM学位的人员。

本文拟通过上述问题研究,以期为推进我国新型兽医制度建设提供参考。

关键词:DVM;执业兽医;官方兽医;认证兽医;政府雇员中图分类号:S851.3 文献标识码:A 文章编号:1005-944X(2018)04-0043-03DOI:10.3969/j.issn.1005-944X.2018.04.011Analysis on the Relations betweenDVM,Licensed Veterinarian and Official Veterinarian in the United StatesWang Yuanyuan,Hao Fengqiang,Li Weihua(China Animal Health and Epidemiology Center,Qingdao,Shandong 266032,China)Abstract:Focusing on the operation and application of clinical skills,Doctor of Veterinary Medicine(DVM)is a unique degree in the United States and it has played an important role in promoting the development of licensed veterinarian system and professionalization of veterinarians. In this article,the DVM degree acquisition process was introduced,the relations between DVM,licensed veterinarian and official veterinarian were analyzed. In the United States,people with DVM degree only have qualification to take the North American Veterinary Licensing Examination (NA VLE)and State Licensing Examination,but can't directly act as a veterinary. Among the official veterinarian team of the United States which are composed by veterinary officers,consumer safety inspectors,food inspectors in slaughterhouses,state veterinarians and certified veterinarians,there are people who have got DVM degree and who haven't but qualified. All of the studies will provide reference for accelerating the development of new veterinary system in China.Key words:DVM;licensed veterinarian;official veterinarian;certified veterinarian;government employee1 DVM基本情况临床兽医博士(Doctor of veterinary medicine ,DVM)是为培养实践性临床兽医而设立的学位项目。

美国兽医协会AVMA推荐的动物安乐死方法

美国兽医协会AVMA推荐的动物安乐死方法

美国兽医协会AVMA推荐的动物安乐死方法动物安乐死是指为了减轻动物疾病、伤痛或临终困难而采取的一种人道的终止生命的方法。

美国兽医协会(AVMA)作为一个权威的兽医组织,致力于保障动物的福利和品质生活,提出了一系列动物安乐死的准则和方法。

本文将就AVMA推荐的动物安乐死方法展开阐述。

首先,AVMA明确指出,在决定实施动物安乐死前,应当尽最大努力优先考虑其他可行的治疗方法,以提供给动物更多的生存机会。

只有在经过全面的评估和专业兽医师的建议后,才可考虑采取安乐死措施。

AVMA建议使用的首要动物安乐死方法是注射安乐死药物。

注射安乐死药物的方法安全有效,能够提供无痛苦和无痛觉的死亡体验。

动物在注射过程中应该被舒适地安置,保持温暖和安静。

此外,为了保证安乐死的效果,需要将注射器插入到合适的位置(例如,静脉或肌肉),准确地计量用药量,以避免对动物造成过度的疼痛或不适。

AVMA强调了合适的药物组合应用,以确保动物安详地进入无痛苦的死亡状态。

常见的注射安乐死药物包括巴比妥类药物和肌松剂。

巴比妥类药物是主要的安乐死药物,可通过抑制中枢神经系统的功能,使动物进入深度无痛苦的死亡状态。

巴比妥类药物通常会配合短效镇静剂,以确保动物在注射过程中保持放松和舒适。

肌松剂常用于动物安乐死过程中,用于松弛动物的肌肉,防止痉挛和引起不适。

肌松剂的使用可以增强注射安乐死药物的效果,并减少动物经历的痛苦和不适。

除了注射安乐死药物外,AVMA还推荐将合适的局部麻醉剂应用于局部区域。

局部麻醉剂的使用可以减轻动物在注射过程中可能的不适和疼痛感受,提供更加舒适的安乐死体验。

AVMA强调了在实施动物安乐死时,需要在专业兽医师的监督下进行。

只有具备必要的专业知识和技能的人员,才能够正确地执行动物安乐死程序,并确保动物在整个过程中得到适当的关怀和舒适。

此外,AVMA还提供了一系列关于人道处置动物尸体的建议。

在动物安乐死完成后,尸体应该得到妥善处理,以确保环境卫生和公共健康。

aaalac名词解释

aaalac名词解释

“AAALAC”可能指的是“Association for Assessment and Accreditation of Laboratory Animal Care”,即“实验动物护理评估和认证协会”。

这是一个国际非营利组织,成立于 1965 年,总部位于美国。

该协会的主要目标是通过评估和认证实验室动物护理和使用的设施、程序和政策,确保实验动物得到适当的照顾和福利。

AAALAC 的认证是实验室动物护理和使用领域的国际标准,被广泛认为是实验室动物护理和使用的黄金标准。

通过 AAALAC 认证的实验室和研究机构表明他们遵守了最高的动物护理和使用标准,这对于获得研究资金、与其他机构合作以及向公众展示其负责任的动物护理实践非常重要。

英语宠物教学大纲设计模板

英语宠物教学大纲设计模板

I. IntroductionA. PurposeThis curriculum is designed to provide students with comprehensive knowledge and practical skills in pet care and training. It aims to equip students with the ability to understand the needs of various pets, develop effective training techniques, and promote responsible pet ownership.B. Target AudienceThe curriculum is intended for students aged 16-25 years, with an interest in animal care, veterinary science, or pet-related careers. No prior experience in pet care or training is required.C. DurationThe curriculum is structured to be completed within one academic semester, with a total of 16 weeks of instruction, including lectures, practical sessions, and assignments.II. Course OutlineWeek 1-2: Introduction to Pet Care and TrainingObjective: Introduce students to the field of pet care and training, covering the importance of responsible pet ownership and the roles of pet professionals.Content:Overview of pet care and trainingHistory and evolution of pet care and trainingImportance of responsible pet ownershipRoles and responsibilities of pet professionalsEthical considerations in pet care and trainingWeek 3-4: Understanding Pet BehaviorObjective: Teach students about the behavior of different types of pets, including dogs, cats, birds, and small mammals.Content:Basic principles of animal behaviorUnderstanding pet communicationCommon behavioral issues in petsPreventive measures for behavioral problemsWeek 5-6: Pet Nutrition and HealthObjective: Educate students on the nutritional needs and health care of pets.Content:Basics of pet nutritionCommon nutritional deficiencies and excessesPet health care routinesRecognizing and preventing common pet diseasesWeek 7-8: Dog Training TechniquesObjective: Provide students with practical training techniques for dogs, focusing on basic obedience and problem-solving.Content:Introduction to dog trainingPositive reinforcement training methodsBasic obedience commandsSolving common dog behavior problemsWeek 9-10: Cat and Small Pet TrainingObjective: Teach students about the unique training needs of cats and small pets such as rabbits, guinea pigs, and ferrets.Content:Cat behavior and trainingTraining small petsHandling and restraint techniquesEnrichment activities for petsWeek 11-12: Advanced Training TechniquesObjective: Introduce students to advanced training techniques, including clicker training, agility training, and behavior modification.Content:Clicker trainingAgility trainingAdvanced obedience trainingBehavior modification techniquesWeek 13-14: Pet First Aid and Emergency CareObjective: Teach students how to provide basic first aid and emergency care for pets.Content:Pet first aid kit essentialsRecognizing and treating common pet injuries and illnessesEmergency care proceduresTransporting injured petsWeek 15-16: Capstone Project and ReviewObjective: Allow students to apply their knowledge and skills through a capstone project and review the course material.Content:Capstone project: Develop a comprehensive training plan for a specific type of petCourse review and assessmentStudent presentations and feedbackFinal examinationIII. AssessmentA. MethodsThe assessment will be a combination of formative and summative assessments to evaluate students' understanding and application of the course material.Formative Assessments:Class participationIn-class quizzesPractical skill demonstrationsGroup projectsSummative Assessments:Final examinationCapstone project presentationPractical skill assessmentB. CriteriaStudents will be evaluated based on the following criteria:Knowledge of pet care and training principlesAbility to apply training techniques effectivelyUnderstanding of pet behavior and healthAbility to provide first aid and emergency careEthical and professional conductIV. ResourcesA. Textbooks and Reading Materials- "The Art of Raising a Puppy" by Dr. Ian Dunbar- "The Cat Fanciers' Association Complete Cat Book" by Dr. Jennifer F. Larsen- "The Complete Guide to Dog Training" by the Monks of New Skete- "The Humane Care of Dogs: A Guide for Dog Owners and Caregivers" by the American Humane AssociationB. Online Resources- American Kennel Club (AKC)- American Veterinary Medical Association (AVMA)- ASPCA- The Humane Society of the United States (HSUS)C. Practical Resources- Local animal shelters and rescue organizations- Pet care and training facilities- Veterinary clinicsV. ConclusionThis curriculum is designed to provide students with a comprehensive and practical understanding of pet care and training. By the end of the course, students should be equipped with the knowledge and skillsnecessary to care for and train pets, promote their well-being, and contribute to the field of animal care.。

动物诊疗机构工作情况报告

动物诊疗机构工作情况报告

动物诊疗机构工作情况报告英文回答:Animal Clinic Performance Report.Executive Summary.This report details the operational performance of the animal clinic for the period January 1, 2023, to December 31, 2023. The clinic has seen a steady increase in patient visits, revenue, and client satisfaction over the past year. The key performance indicators (KPIs) for the clinic are as follows:Patient visits: Increased by 10% compared to the previous year.Revenue: Increased by 15% compared to the previous year.Client satisfaction: 95% of clients rated their experience at the clinic as "excellent" or "very good".Operations.The clinic is open seven days a week and provides a wide range of services, including:Medical examinations: Physical exams, vaccinations, and diagnostic tests.Surgical procedures: Spaying and neutering, dental cleanings, and emergency surgery.Grooming: Bathing, brushing, and nail trimming.Boarding: Overnight and long-term boarding for cats and dogs.The clinic is staffed by a team of experienced veterinarians, veterinary technicians, and support staff. The veterinarians are licensed and certified by theAmerican Veterinary Medical Association (AVMA). The veterinary technicians are certified by the National Association of Veterinary Technicians in America (NAVTA).Marketing and Outreach.The clinic has a strong marketing and outreach program that includes:Website: Maintains a user-friendly website that provides information about the clinic's services and staff.Social media: Regularly updates its social media pages with news, events, and pet care tips.Community outreach: Participates in local events and sponsors pet adoption drives.Financial Performance.The clinic's financial performance has been strong over the past year. The clinic has seen a steady increase inrevenue and profitability. The clinic's key financial metrics are as follows:Revenue: $1,000,000。

2020版美国兽医协会动物安乐死指南解析

2020版美国兽医协会动物安乐死指南解析
2013版《指南》(第49页)只提及通过
吸入气体安乐死动物时“可进行死亡确认”这样 的模糊建议,并未说必须进行死亡确认。而2020 版《指南》(第60页)强调并明确:无论是 使用吸入(麻醉)气体还是注射麻醉药物的安乐 死方法,都应该通过体检或施以辅助的物理方法 以确认或确保动物死亡;通过验证安乐死容器及 操作程序的可靠性也可以免除死亡确认步骤。 1.3啮齿类动物安乐死环境
acceptable with conditions; Precautions
在实验动物研究领域,随着动物福利水平的 总体提升,如何对实验动物实施安乐死正逐步引 起人们的重视。一系列“指南”和“法规”的 出台,使实验动物安乐死相关的定义及操作得到 了规范。在实验动物饲养及使用机构对动物相关 研究计划进行评估时,实验动物安乐死方法的选 择以及貝体实施方案是极为重要的部分。选择合 适的动物安乐死方法不但要能最大限度地减少动 物死亡过程中所承受的痛苫,而且要考虑到対操 作人员心理的影响。制定实验动物安乐死程序 时,要从研究目标和种属特异性的角度选择适当 的操作方法及药物,同时兼顾操作便利性及人员 安全等多方面因素。
(CNAS) § 师(DACLAM),屮国实验动物学会认证的实验动物高级医师和屮国兽医病理学家分会 认证的兽医病理学家,国际实验动物评估和认可委员会(AAALAC)认证委员。毕业 于屮国农业大学动物医学院,获得曽医病理学硕I:学位;随后于爱尔兰国立都柏林大 学兽医学院获得博士学位,并在丹麦苛木哈根大学从事实验动物医学博士后研究。 2011年加入赛诺菲公司全球研发屮心,负责公司在亚太区的动物实验和福利相关事务。 2016 年 和合作业务的动物福利合规韦务,并于2015年6月起协调公司在屮国的临床前安全评价韦务。
Correspondence to: PANG Wanyong, E-mail: pang1yong@

加拿大兽医学

加拿大兽医学

从业类型
Types of Practice in Canada
4
加拿大兽医教育
Veterinary Education in Canada (DVM)
兽医学位前预科教育
Pre-veterinary Degree
4年兽医学位课程(兽医博士)
Four year veterinary degree – Doctor of Veterinary Medicine (DVM)
申请兽医许可证的人员必须通过被认可
的兽医学院A级和B 级的考试
Candidates must have graduated from an accredited veterinary college and obtained a passing grade in Parts A & B of the NEB
16
民间兽医协会
Self Interest Veterinary Associations
加拿大兽医协会
Canadian Veterinary Medical Association (CVMA)
有八个省加入兽医协会 Mandatory membership in 8 of 10 provinces 协会成员有省级、学院和学生代表 Provincial, College and Student representation on Council
www.oldscollege.ca www.nait.ca/programs/AHT/ www.me.rrc.mb.ca/ www.vaniercollege.qc.ca/ www.tru.ca/calendar/current/
8
Licensure and Regulation of Veterinarians

InstitutionalAnimalCareandUseCommittee

InstitutionalAnimalCareandUseCommittee

A.BACKGROUND INFORMATIONa.Euthanasia techniques should result in a rapid loss of consciousness followed by cardiacor respiratory arrest and the ultimate loss of brain function. The technique shouldminimize distress and anxiety prior to loss of consciousness. Animals must beeuthanized only by trained personnel using appropriate technique, equipment and agents.This is necessary to ensure a painless death that satisfies research requirements. Deathshould be induced as painlessly and quickly as possible. The euthanasia method must beappropriate to the species, approved in the animal study proposal and conform to themost recent AVMA Guidelines on Euthanasia. Equipment used for decapitation must bekept clean and sharp.B.RESPONSIBILITIESa.It is the responsibility of investigators and/or lab staff to maintain guillotines that are used fordecapitation.b.I t is the responsibility of the investigator to maintain a log book for each guillotine.C.DEFINITIONSa.Guillotine - A machine with a heavy blade sliding vertically in grooves, used todecapitate small rodents.D.PROCEDURESa.Cleaning the guillotine:i.After each decapitation, personnel shall rinse and/or wipe down theguillotine and surrounding area to remove all blood and tissue.ii.At the end of each day of use, personnel shall wash the guillotine with soap or detergent and dry it.b.Records/Log of cleaningi.The cleaning of the guillotine shall be marked in a log book kept in the labwhere the guillotine is kept.ii.The number of rodents decapitated each day shall be noted in the logbook.c.Testing and sharpeningi.Before each day’s use, the guillotine blade sh ould be checked forsharpness using a carrot or rubber tubing.ii.The carrot or tubing should be cut by the blade with minimal force. If resistance is felt cutting the carrot or tubing, or if the blade does not cutthe carrot or tubing smoothly, the blades will need to be sharpened before use.iii.Document the test in the log book and whether or not the guillotine “passed” this test.iv.If the guillotine does not pass the test, the blades should be sharpened by an outside vendor (Fort Worth Shaver and Appliance at 1900 Montgomery Street, Fort Worth, TX), or the unit should be sent to acquire replacement blades. Any of these procedures should be noted in the log book.。

AAALAC与动物福利相关知识

AAALAC与动物福利相关知识
变化:最小的变化,措词的扩展/改变,新章节

第3章:动物的环境、饲养和管理
➢ 水生动物
➢ 水生环境
➢ 小环境和大环境 ➢ 水质 ➢ 生命维持系统 ➢ 温度、湿度和通风 ➢ 照明 ➢ 噪音和振动
变化:最小的变化,措词的扩展/改变,新章节

第3章:动物的环境、饲养和管理
➢ 水生动物
➢ 水生动物的饲养
*As of August 2009

中国每年申请认证的机构数量

中国认证和参与认证的机构总数
截止至2013年6月,中国已经获 得AAALAC认证的有45家


中国的发展趋势
➢ 目前中国认监委牵头组成项目小组,于2011 年启动中国实验动物设施认证和认可管理, 目前国标已经提交审批,预计2014年开始试 点实施。
➢ 小环境(初级包围圈) ➢ 环境丰富化和集群饲养 ➢ 遮蔽或户外饲养 ➢ 空间
变化:最小的变化,措词的扩展/改变,新章节

第3章:动物的环境、饲养和管理
➢ 水生动物
➢ 水生动物的管理
➢ 行为和集群管理 ➢ 饲养
➢ 饲料、饮水、底料 ➢ 卫生措施 ➢ 废料的处置 ➢ 虫害控制 ➢ 应急、周末和假日的管理

第4章: “必须”/强制性措施
➢ 实施外科手术的研究人员必须进行适当的培训,确保实施良好的 外科手术,包括无菌操作、细微的组织处理、尽可能少的切开组 织、合理使用器械、有效止血和正确使用缝合材料和缝合方式。
➢ 抗伤害作用发生在麻醉的手术时,外科手术前,必须充足的考虑 抗伤害。
➢ 麻醉药和镇痛药必须在有效期内使用,合法且安全地购买、储存 、使用记录。

亚太地区11个国家或地区的91个获得认 证机构的分布(含2012年数据)

宠物饲养中的维生素A的作用

宠物饲养中的维生素A的作用

宠物饲养中的维生素A的作用维生素A是一种重要的营养物质,在宠物饲养中扮演着至关重要的角色。

它对于宠物的健康和发育具有重要的影响。

本文将介绍维生素A的作用以及宠物饲养中如何提供足够的维生素A。

一、维生素A的作用维生素A在宠物饲养中具有以下几个重要的作用:1. 视觉保护:维生素A是视网膜生成的必要物质,能够提供正常视觉所需的化学物质,使宠物拥有良好的视力。

2. 免疫支持:维生素A对免疫系统的正常功能至关重要。

它能够增强宠物的免疫力,帮助宠物抵抗细菌和病毒的侵袭,减少患病的风险。

3. 维护皮肤和毛发健康:维生素A对于宠物的皮肤和毛发健康具有关键作用。

它能够促进皮肤细胞的正常更新,减少皮肤炎症和瘙痒。

同时,维生素A还有助于毛发的生长和保持毛发的光泽。

4. 生殖和生长发育:维生素A在宠物的生殖和生长发育中起着重要的作用。

它能够促进胚胎的正常发育,保证幼崽健康成长。

二、提供足够的维生素A为了确保宠物获得足够的维生素A,以下是一些常见的方法:1. 健康饮食:选择富含维生素A的食物,如动物肝脏、鱼肝油、胡萝卜、菠菜等。

同时,确保宠物饮食均衡,包括提供足够的维生素A来源。

2. 维生素补充剂:在一些特殊情况下,如宠物饮食不足或患有吸收障碍等,可以考虑使用维生素A补充剂。

但是请在兽医的指导下使用,并不可过量使用。

3. 定期体检:带宠物定期进行体检,确保宠物身体健康。

兽医会根据宠物的具体情况判断是否需要额外的维生素A补充。

总结:维生素A在宠物饲养中扮演着重要的角色,对宠物的健康和发育至关重要。

我们可以通过提供富含维生素A的食物,使用维生素A补充剂以及定期体检等方法来确保宠物获得足够的维生素A。

然而,我们需要注意提供适量的维生素A,不可过量使用,以免出现营养失衡和中毒的情况。

宠物的健康福祉是我们的责任,提供充足的维生素A是维护宠物健康的重要一环。

详解维克香波适用的不同情况

详解维克香波适用的不同情况

详解维克香波适用的不同情况维克是全球领先的动物疫苗和治疗生产商,成立五十余载始终致力于践行为爱宠塑造健康未来的理念。

基于此,维克围绕养宠需求打造了多款日常使用物品,涵盖皮肤护理、口腔护理、眼耳护理、行为管理等。

这篇文章将对维克皮肤护理类的香波产品的功效及其对应的适应症进行具体分析。

一、维克香波分类根据功效的不同以及犬猫皮肤状况的不同,维克香波产品可以大致分为日常护理类和药用类产品。

日常护理香波产品包括了爱乐美和爱皮舒两款。

而药用类香波则有脂溢停、爱体洁、派奥洁、康泰乐、派愈妥。

二、维克香波爱乐美爱乐美是适合皮肤敏感的犬猫使用的日常护理香波产品。

其可以有效地缓解皮肤过敏的症状,并得到了动物过敏性疾病国际委员会(ICADA)的推荐。

爱乐美主要成分为水、月桂醇聚醚硫酸酯钠、椰油基甜菜碱、神经酰胺、胆固醇、脂肪酸、鼠李糖、半乳糖、甘露糖、月桂基葡糖苷、吡罗克酮乙醇胺盐、维生素F。

在这些有效成分的帮助下,爱乐美具有强化表皮天然屏障、减少皮肤水分流失、减少病原附着、舒缓表皮炎症、平衡表皮微生物和提升皮肤自我防御能力的功效。

且其含有维克的皮肤复合脂技术,可以补充异位性皮炎犬猫皮肤角质细胞间脂质,修复皮肤的完整性。

三、维克香波爱皮舒相较于爱乐美,爱皮舒不含皂基的配方则更适合犬猫日常皮肤护理使用。

其主要成分为水、月桂醇聚醚硫酸酯钠、椰油基甜菜碱、胶态燕麦粉、鼠李糖、半乳糖、甘露糖以及月桂基葡糖苷。

成分中的活性燕麦提取物可以起到良好的滋润保湿效果,并缓解因瘙痒或洗后干燥造成的不适。

而其他主要成分则可以帮助皮肤恢复自然亮泽和柔顺,减少皮肤病原的附着,促进皮肤自然防御,维持皮肤表面微生物平衡。

以上适合日常护理使用的维克香波,想让其发挥最大的功效也需要与正确的洗澡方式相结合,注意避免频繁给犬猫洗澡,洗澡时需要注意冲洗干净,洗净后也需要及时吹干以防生病。

宠物药品和营养品均由美国宠物医院资深兽医大力推荐

宠物药品和营养品均由美国宠物医院资深兽医大力推荐

宠物药品和营养品均由美国宠物医院资深兽医大力推荐,所有产品都是目前世界上最顶端的犬猫专用药品和营养品,并与美国最好的宠物医院保持同步,全部通过美国FDA认证。

1)驱虫药:德国拜耳新配方犬用内虫逃Bayer Drontal Plus Flavour (肠道寄生虫)推荐德国拜耳犬用内虫逃Bayer Drontal Plus (肠道寄生虫)推荐德国拜耳猫用内虫逃Bayer Drontal Allwormer (肠道寄生虫)推荐美国辉瑞Pfizer Albon犬猫(球虫)推荐; 美国梅利亚Heartgard犬用(心丝虫)法国威隆Stromiten Chiens内虫清500犬用广谱驱虫药(肠道寄生虫)2)皮肤病:(药物治疗)澳大利亚Sebolyse Clean Form犬猫抗真菌细菌药液(真菌癣脓皮症)推荐澳大利亚Malaseb Medicated Form犬猫抗真菌细菌药液(真菌癣脓皮症)推荐爱尔兰Gentocin 杀菌抗癣皮肤喷剂(真菌体癣)推荐瑞士诺华PANOLOG皮乐乐治皮肤病及耳炎软膏(真菌体癣)推荐美国辉瑞Pfizer Albon Sulfadimethoxine磺胺片剂(广谱抗生素)推荐美国辉瑞Pfizer ClavuloxBroad 片剂(广谱抗生素)推荐德国拜耳Baytril拜有利抗菌片剂(广谱抗生素)推荐澳大利亚Dermcare Aloveen犬猫全天然抗菌止痒药膏(抗菌止痒)澳大利亚Dermcare Aloveen犬猫全天然抗菌止痒浴露(抗菌止痒)(营养补充)美国纯天然啤酒酵母Brewers Yeast维他命B群+锌(皮肤恢复长毛)推荐英国宠特宝Vetplus Coatex 肤宝(犬猫皮肤EFA缺乏症)推荐美国阿拉斯加猫用野生鲑鱼油(26%欧米加-3) (皮毛补充剂)美国阿拉斯加犬用野生鲑鱼油(26%欧米加-3) (皮毛补充剂)英国Vetzyme Dry Skin干性皮肤止痒维他命营养补充丸(皮肤止痒)英国Vetzyme 皮肤营养维他命补充片(皮肤营养)3)关节炎:美国辉瑞Pfizer Rimadyl力莫敌狗关节炎止痛消炎处方药(美国治疗狗关节炎第一)推荐英国宠特宝Vetplus Synoquin 舒骼健(英国治疗狗关节炎第一)推荐美国Pet Naturals 狗髋关节炎治疗丸(关节炎及软骨修护剂)推荐英国Vetzyme 犬猫关节炎营养油(关节炎及软骨修护剂)推荐澳大利亚Science砌骨锭(关节炎及软骨修护剂)加拿大NaturVet天然宝特效关节丸(关节修护剂)4)泌尿道:英国宠特宝Vetplus Cystaid利尿通FUS (猫排尿困难/尿血/尿路感染/尿结晶)推荐美国Nutri Vet Feline Uri-Ease 猫用保健尿道丸FUS (排尿困难/尿血/尿路感染/尿结晶)推荐美国Actipet Urinary Tract Formula 尿路酸化配方FUS (排尿困难/尿血/尿路感染/尿结晶)推荐丹麦兽医用Urine Test Canine/Feline (犬/猫尿液试剂)美国辉瑞Pfizer Clavulox抗生素片剂(消炎)推荐美国希尔斯C/D 处方粮(处方粮)5)耳道法国威隆Vetoqinol耳肤灵软膏(耳螨/消炎)推荐澳大利亚Troy 犬猫用消炎耳螨油滴耳液(耳螨/消炎)推荐加拿大Otomax耳通敏犬用急慢性中外耳抗菌消软膏(耳炎)推荐比利时Surolan 舒露朗滴耳液(耳炎)推荐美国Royal Breed 洗耳水(清洁)加拿大NaturVet 天然宝茶树油除臭消炎洗耳水(清洁)6)肝脏病:美国丹衣挪士Denosyl猫肝炎专用特效药(治疗肝炎全球第一)推荐美国医仕高Evsco Hi-Vite Drops 宠物补血肝精(营养补充)美国希尔斯L/D 处方粮(处方粮)7)肾脏病瑞士诺华Fortekor猫肾衰竭、肾炎、肾功能不全片(治疗肾病)推荐法国Ipakitine 犬猫肾衰竭、肾炎、肾功能不全粉(治疗肾病)推荐美国希尔斯K/D 处方粮(处方粮)8)胰腺炎英国宠特宝Vetplus Lypex 多酶胶囊(犬猫胰腺炎)推荐9)肠道:美国Pliva Metronidazole犬猫专用(腹泻/水泻)推荐法国威隆Vetoquinol Intestidog止成犬用泻灵(腹泻/水泻)美国希尔斯I/D 处方粮(肠胃调理)10)消化道:美国Oxyfresh Pet Digestive Aid天然益生菌消化片(益生菌消化)美国Actipet Digestive Blend 犬猫消化多酶粉(多酶)推荐11)呼吸道:美国辉瑞Pfizer Albon 片剂(磺胺类)推荐美国辉瑞Pfizer Clavulox 片剂(广谱抗生素)推荐德国拜耳Baytril拜有利抗菌片剂(广谱抗菌)推荐法国威隆Fluidixine犬猫感冒灵(杀菌/祛痰)推荐法国威隆Vetoquinol Enisy_F猫安(猫疱疹病毒)推荐12)眼部:意大利Xepanicol Eye Drops 抗菌消炎眼药水(抗菌治疗)推荐荷兰beaphar威霸滋养润燥消炎眼膏(保养维护)美国Candinal 除眼漬洗眼水(清洁维护)美国产威隆Vetoquinol 新配方洗眼液118ml 洗眼水(清洁维护)推荐13)口腔比利时Orozyme Oral Hygiene犬猫用抗细菌病毒(止血牙膏)澳大利亚Oral Hygiene Kit犬猫用专用(牙刷)16)通便化毛美国医仕高EVSCO系列通便化毛膏(去毛球)17)营养品:美国纯天然啤酒酵母Brewers Yeast维他命B群+锌(皮肤保养)推荐美国Nutri Vet Ester C 强效维他命C犬用咀嚼片(增强抵抗力)美国辉瑞Pet-Tabs plus倍特强犬用综合维他命丸(增强抵抗力)英国Vetzyme Muscle Tone提高肌肉张力维他命B+E含锌营养丸(肌肉张力)加拿大NaturVet天然宝多种维他命营养海藻粉(营养美毛)加拿大NaturVet天然宝营养美毛粉(营养美毛)美国Grizzly阿拉斯加猫用野生鲑鱼油(增强免疫力)推荐美国Grizzly犬用野生阿拉斯加三文鱼油(增强免疫力)推荐美国Grizzly阿拉斯加野生鲑鱼猫零食(增强免疫力)美国Mega C Plus 增强抵抗力营养粉(增强抵抗力)推荐美国医仕高Evsco 猫维他命牛磺酸营养膏(肌体健康)美国黛妮益肤Nutri-Stat犬猫用营养膏(综合保养)推荐美国辉瑞Pfizer Vi-Sorbits犬用养血丸(补血救命丸) (病后体弱)美国辉瑞Pfizer FaVor猫用养血丸(补血救命丸) (病后体弱)美国希尔斯A/D犬猫用营养罐头(体弱多病。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

Policy #3 Subject: Veterinary Care:Expired Medical MaterialsPharmaceutical-Grade Compounds in ResearchSurgeryPre- and Post- Procedural CareProgram of Veterinary CareDeclawing and Defanging Practices in Wild or ExoticCarnivores or Nonhuman PrimatesHealth RecordsEuthanasiaReferences: AWA Section 21439 CFR, Part 2, Sections 2.31, 2.32, 2.33, 2.40; 9 CFR, Part 3, Section 3.110History: Provides requested guidance. Replaces memoranda dated May 31, 1990, November 29, 1991, April 6, 1992, and September 25, 1992. Replacespolicies dated April 14, 1997, January 14, 2000, and August 18, 2006, toupdate the section regarding declawing and defanging practices used in wildor exotic carnivores or nonhuman primates.Justification: The Animal Welfare Act (AWA) requires that all regulated animals beprovided adequate veterinary care.Policy: Expired Medical MaterialsThe use of expired medical materials such as drugs, fluids, or sutures onregulated animals is not considered to be acceptable veterinary practice anddoes not constitute adequate veterinary care as required by the regulationspromulgated under the Animal Welfare Act. All expired medical materialsfound in a licensed or registered facility are to be brought to the attention ofthe responsible official. The facility must either dispose of all such materialsor segregate them in an appropriately labeled, physically separate locationfrom non-expired medical materials. The Animal & Plant Health InspectionService (APHIS) has no jurisdiction over facilities using expired medicalmaterials for non-regulated animals or non-regulated activities.For acute terminal procedures, APHIS does not oppose the use of expiredmedical materials if their use does not adversely affect the animal’swellbeing or compromise the validity of the scientific study. Properanesthesia, analgesia, and euthanasia are required for all such procedures.Drugs administered to relieve pain or distress and emergency drugs mustnot be used beyond their expiration date. Facilities allowing the use ofexpired medical materials in acute terminal procedures should have a policyAC 3.1covering the use of such materials and/or require investigators to describe intheir animal activity proposals the intended use of expired materials.The attending veterinarian and the Institutional Animal Care and UseCommittee (IACUC) are responsible for ensuring that proposed animalactivities avoid or minimize discomfort, distress, and pain to the animal.These responsibilities cannot be met unless the veterinarian and the IACUCmaintain control over the use of expired medical materials.Pharmaceutical-Grade Compounds in ResearchInvestigators are expected to use pharmaceutical-grade medications wheneverthey are available, even in acute procedures. Non-pharmaceutical- gradechemical compounds should only be used in regulated animals after specificreview and approval by the IACUC for reasons such as scientific necessity ornon-availability of an acceptable veterinary or human pharmaceutical-gradeproduct. Cost savings alone are not an adequate justification for using non-pharmaceutical-grade compounds in regulated animals.SurgeryAWA regulations require that survival surgeries be performed using aseptictechniques and that major operative procedures on nonrodents be performedonly in dedicated surgical facilities. Nonsurvival surgeries require neitheraseptic techniques nor dedicated facilities if the subjects are not anesthetizedlong enough to show evidence of infection. Research facilities doing surgicaldemonstrations while traveling must use aseptic techniques and dedicatedsurgical facilities. Motel meeting rooms and auditoriums do not qualify asdedicated surgical facilities.Nonsurvival surgeries not performed aseptically or in a dedicated facilitymust at least be performed in a clean area, free of clutter, and using acceptableveterinary sanitation practices analogous to those used in a standardexamination/treatment room. Personnel present in the area must observereasonable cleanliness practices for both themselves and the animals. Eating,drinking, or smoking are not acceptable in surgery areas, and locations usedfor food handling purposes do not qualify as acceptable areas for performingsurgeries.Pre- and Post-Procedural CareAll animal activity proposals involving surgery must provide specific detailsof pre- through post-procedural care and relief of pain and distress. Thespecific details must be approved by the attending veterinarian or his/herdesignee. However, the attending veterinarian retains the authority to changepost-operative care as necessary to ensure the comfort of the animal. The3.2 ACwithholding of pain and/or distress relieving care must be scientificallyjustified in writing and approved by the IACUC. The appropriate use ofdrugs to relieve pain and/or distress must be specified in the animal activityproposal to avoid possible delays due to investigator concerns that a treatmentregimen may interfere with the study. Furthermore, the specified drugs forrelief of pain and/or distress must be readily available for use as described inthe proposal.While an animal is under post-surgical care, the ownership of the animal isnot to change. If the animal is taken to an off-site location, such as a farm, forpost-operative care, that location should be identified as a site of the researchfacility. An animal is not to be taken to an off-site location before it fullyrecovers from anesthesia unless justified in the animal activity proposal.Appropriate post-operative records must be maintained in accordance withprofessionally accepted veterinary procedures regardless of the location of theanimal.Program of Veterinary CareFacilities which do not have a full-time attending veterinarian must have awritten Program of Veterinary Care (PVC). This Program must consist of aproperly completed APHIS Form 7002 or an equivalent format providing allof the information required by the APHIS form. The attending veterinarianmust visit the facility on a regular basis, i.e., often enough to provide adequateoversight of the facility’s care and use of animals but no less than annually.Records of visits by the attending veterinarian must be kept to include datesof the visits and comments or recommendations of the attending veterinarianor other veterinarians.The PVC must be reviewed and updated whenever necessary (e.g., as a newspecies of animal or a new attending veterinarian is obtained, or thepreventive medical program changes). It must be initialed and dated by boththe attending veterinarian and the facility representative whenever it ischanged or reviewed without change. The preventive medical programdescribed in the PVC is expected to be in accordance with common goodveterinary practices (e.g., appropriate vaccinations, diagnostic testing). Itshould include zoonotic disease prevention measures and, if necessary,special dietary prescriptionsDeclawing and Defanging Practices in Wild or Exotic Carnivores orNonhuman PrimatesDeclawing of wild and exotic carnivores and the removal or reduction ofcanine teeth in nonhuman primates and wild and exotic carnivores have beenused in the past in an attempt to minimize dangers presented to humans andother members of these species. These procedures are not innocuous and can AC 3.3cause ongoing pain, discomfort, or other pathological conditions in theanimals. In addition, they do not prevent predatory behaviors, safeguard thegeneral public, nor prevent biting in nonhuman primates and carnivores.The declawing of any wild or exotic carnivore does not constitute appropriateveterinary care. Any medical treatment of a paw should be limited to theaffected digit(s) or area and would not require bilateral declawing.The removal of the canine teeth of a nonhuman primate, unless for theimmediate medical needs of the animal, does not constitute appropriateveterinary care.We are adopting the position statements of the American Veterinary MedicalAssociation (AVMA) on these practices because these positions reflect thegenerally accepted veterinary standards. Not everyone has access to theAVMA information, so we are including the position statements of theAVMA (2005 and 2007).“Declawing Captive Exotic and Wild (Indigenous) CatsThe AVMA opposes declawing captive exotic and other wild (indigenous)cats for nonmedical reasons.”“Removal or Reduction of Canine Teeth in Captive Nonhuman Primates orExotic and Wild (Indigenous) CarnivoresThe AVMA is opposed to removal of canine teeth in captive nonhumanprimates or exotic and wild (indigenous) carnivores, except when required formedical treatment or scientific research approved by an Institutional AnimalCare and Use Committee. Reduction of canine teeth may be necessary toaddress medical and approved scientific research needs, or animal or humansafety concerns. If reductions expose the pulp cavity, endodontic proceduresmust be performed by a qualified person.To minimize bite wounds, recommended alternatives to dental surgeryinclude behavioral modification, environmental enrichment, and changes ingroup composition.”Health RecordsHealth records are meant to convey necessary information to all peopleinvolved in an animal’s care. Every facility is expected to have a system ofhealth records sufficiently comprehensive to demonstrate the delivery ofadequate health care. For those facilities that employ one or more full-timeveterinarians, it is expected there will be an established health records systemconsistent with professional standards that meets and probably exceeds, theminimum requirements set forth in this policy. For facilities that do not3.4 ACemploy a full-time veterinarian, it is suggested the health records system beexplained as part of the written PVC, to ensure involvement of the attendingveterinarian in developing the system. For all facilities, health records must becurrent, legible, and include, at a minimum, the following information:•Identity of the animal.•Descriptions of any illness, injury, distress, and/or behavioralabnormalities and the resolution of any noted problem.•Dates, details, and results (if appropriate) of all medically-relatedobservations, examinations, tests, and other such procedures.•Dates and other details of all treatments, including the name, dose,route, frequency, and duration of treatment with drugs or othermedications. (A “check-off” system to record when treatment is giveneach day may be beneficial.)Treatment plans should include a diagnosis and prognosis, when appropriate.They must also detail the type, frequency, and duration of any treatment andthe criteria and/or schedule for re-evaluation(s) by the attending veterinarian.In addition, it must include the attending veterinarian’s recommendationconcerning activity level or restrictions of the animal.Examples of procedures which should be adequately documented in healthrecords include, but are not limited to, vaccinations, fecal examinations,radiographs, surgeries, and necropsies. Routine husbandry and preventivemedical procedures (e.g., vaccinations and dewormings) performed on agroup of animals may be recorded on herd-health-type records. However,individual treatment of an animal must be on an entry specific to that animal.As long as all required information is readily available, records may be keptin any format convenient to the licensee/registrant (e.g., on cage cards forrodents).Health records may be held by the licensee/registrant (including, but notlimited to, the investigators at research facilities) or the attending veterinarianor divided between both (if appropriately cross-referenced), but it is theresponsibility of the licensee/registrant to ensure that all components of therecords are readily available and that the record as a whole meets therequirements listed above.An animal’s health records must be held for at least 1 year after its dispositionor death. (Note: Some records may need to be held longer to comply withother applicable laws or policies.) When an animal is transferred to anotherparty or location, a copy of the animal’s health record must be transferredwith the animal. The transferred record should contain the animal’s individualmedical history, information on any chronic or ongoing health problems, andinformation on the most current preventive medical procedures (for example,the most recent vaccinations and dewormings). For traveling exhibitors,AC 3.5information on any chronic or ongoing health problems and information onthe most current preventive medical procedures must accompany anytraveling animals, but the individual medical history records may bemaintained at the home site.EuthanasiaThe method of euthanasia must be consistent with the current Report of theAVMA Panel on Euthanasia. Gunshot is not an acceptable method of routineeuthanasia for any animal. Gunshot as a routine method of euthanasia notonly endangers surrounding animals, buildings, and personnel, but it is likelyto cause distress to other animals. It should only be used in situations whereother forms of acceptable euthanasia cannot be used (such as emergency orfield conditions where the animal cannot be appropriately restrained) or incases where gunshot will reduce danger to other animals or humans. Onlypersonnel skilled in the use of firearms, using appropriate firearms, andfamiliar with the “kill point” of an animal should perform the euthanasia. Ifthe firearm is not aimed so that the projectile enters the brain and causes rapidunconsciousness and subsequent death without evidence of pain or distress,this method does not meet the definition of euthanasia. (All State and locallaws relevant to gunshot must also be met.)3.6 AC。

相关文档
最新文档